Patient treatment options for hidradenitis suppurativa have been approved by the FDA for the first time.

Published Date: 03 Nov 2023

Secukinumab is the first novel biologic therapy option for moderate to severe hidradenitis that has been approved by the US Food and Drug Administration (FDA).

Read Full News

Latest News

Luigi Mangione Admits Killing Insurance CEO, Pleads Guilty in Federal Case

Luigi Mangione admitted in court on Friday that he fatally shot health insurance executive Brian Thompson and pleaded guilty to two federal charges of stalking the CEO with...

AstraZeneca Suffers Another Setback as It Halts Volrustomig Lung Cancer Trial

AstraZeneca said it is ending a late-stage trial that combined one of its key experimental drugs with chemotherapy to treat a certain type of lung cancer, extending a ⁠run...

Nestle Looks to Develop New Products to Serve Users Of Weight-loss Drugs

Nestle is seeking to turn the rise of GLP-1 weight-loss drugs from a threat into a business opportunity, using artificial intelligence and nutritional science to develop...

US Kindergarten Vaccine Coverage Continues Downward Trend, Falling 0.1%

U.S. kindergarten vaccination coverage fell 0.1% during the 2025-2026 school year, continuing a downward trend that has seen declines every year except one since the onset...

‘Squishy’ Toy Warning After Children Suffer Serious Burns

Burn specialists report serious injuries after children heat gel-filled toys, prompting authorities to warn families against microwaving them or using them improperly.

Topical Finasteride Effective for Hair Loss in Men

Topical finasteride 0.25% monotherapy demonstrates sustained effectiveness and a favourable safety profile in men with androgenetic alopecia over 52 weeks.

Todays Updates

Belgian Algorithm Reshapes Endometrial Cancer Care

A new Belgian algorithm may help clinicians choose adjuvant therapy more precisely in early endometrial cancer, moving beyond TNM staging alone.

Todays Updates

Belgian Algorithm Reshapes Endometrial Cancer Care

A new Belgian algorithm may help clinicians choose adjuvant therapy more precisely in early endometrial cancer, moving beyond TNM staging alone.

Latest News

Luigi Mangione admitted in court on Friday that he fatally shot health insurance executive Brian Thompson and pleaded guilty to two federal charges of stalking the CEO with...

AstraZeneca said it is ending a late-stage trial that combined one of its key experimental drugs with chemotherapy to treat a certain type of lung cancer, extending a ⁠run...

Nestle is seeking to turn the rise of GLP-1 weight-loss drugs from a threat into a business opportunity, using artificial intelligence and nutritional science to develop...

U.S. kindergarten vaccination coverage fell 0.1% during the 2025-2026 school year, continuing a downward trend that has seen declines every year except one since the onset...

Burn specialists report serious injuries after children heat gel-filled toys, prompting authorities to warn families against microwaving them or using them improperly.

Topical finasteride 0.25% monotherapy demonstrates sustained effectiveness and a favourable safety profile in men with androgenetic alopecia over 52 weeks.

News All Time

Hemangiomas: Absence of One Feature May Rule Out Syndrome

A systematic review of patients with LUMBAR syndrome found that the anatomic midline was involved in all cases, raising the possibility that this is a diagnostic criterion.

Hyperinsulinemic Hypoglycemia: Looking Beyond Insulinoma?

A distinctive metabolic signature may identify rare insulin receptor disorders earlier, helping clinicians avoid unnecessary insulinoma investigations.

FDA Approves Replimune Skin Cancer Drug After Rejections

The accelerated approval follows FDA concerns about the single-arm evidence supporting the treatment.

TikTok Turns Isotretinoin Into a Beauty Trend

Social media has fueled new demand for isotretinoin, but the drug’s true value and its best-known risks remain defined by evidence, not influencer hype.

Combo Therapy May Clear Stubborn Warts Faster

Combining topical urea with carboxytherapy may help reduce lesion size more effectively and achieve faster clearance than urea alone in patients with treatment-resistant common warts.

Manufacturer Files for Botox Approval for Jawline Contouring

After positive findings from phase 3 trials, Allergan Aesthetics submits sBLA to the FDA for onabotulinumtoxinA, to improve the appearance of the masseter muscle.

Surgeons Warn of 'Regulatory Gap' in Cosmetic Surgery

Surgical royal colleges warn the government's delayed consultation leaves patients exposed to under-qualified practitioners.

Deucravacitinib Shows Sustained Efficacy and Safety in PsA

Deucravacitinib shows greater efficacy than placebo in adults with active psoriatic arthritis at week 16, with sustained benefits through week 52 and a well-tolerated safety profile.

CSCC Incidence, NMSC Mortality Rise in England

The incidence of keratinocyte cancer rose in England from 2013 to 2022, with a stabilising incidence of BCC, an increasing incidence of cutaneous squamous cell carcinoma, and rising NMSC mortality.

Methotrexate Continuation in Psoriatic Disease Differs by Sex

Dutch data highlight the importance of considering sex-specific differences in methotrexate drug survival when prescribing it to patients with psoriatic disease.

Lactate: An Alternative to pH in Fetal Blood Sampling?

Lactate and pH in fetal scalp blood samples show moderate inverse correlation, with a proposed lactate cutoff of ≥ 5.6 mmol/L demonstrating an optimal sensitivity-specificity balance.

Precursor Keratinocyte Lesions Increased in SLE

Patients with systemic lupus erythematosus have higher risks for actinic keratosis and squamous cell carcinoma in situ, in a patient registry analysis.

Two Studies Evaluate RF Microneedling Adverse Event Reports

Fat loss is an often-reported complication following radiofrequency microneedling, two new studies show. But experts are pushing back on both the findings and a recent FDA warning.

Tirzepatide Enhances Outcomes in Obesity With PsA

Patients with obesity and PsA starting tirzepatide alongside biologic therapy reported significantly better symptom control and functional status than those on biologics alone.

Reassurance Not Recommended for Teens With Skin-Focused BDD

Teenagers with skin-related body dysmorphia seeing a dermatologist are not typically helped and might be harmed by simple reassurances that do not address the root problem, an expert maintains.

Smallpox DNA Is Recovered From Spanish Conquest-era Chilean Mummies

When Spanish conquistadors arrived in the New World some five centuries ago, they brought muskets, cannons, armor, horses and attack dogs as they set about colonizing the...

Recommended News For You

Orca-T Approved to Prevent GVHD After Stem Cell Transplant for Blood Cancers

The Early Progression of Prostate Cancer Is Not Stopped by Metformin.

Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing

Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.

Global warming could be driving up women's cancer risk, find researchers

Enhanced CAR T cell therapy offers new strategy for lymphoma

Urinary tract cancer prediction models with high sensitivity and specificity

Recommended Articles For You

Exploring The Science Of Hematopoietic Stem Cell Transplantation: What You Need To Know 

Revolutionizing Thyroid Cancer: Advances in Molecular Genetics and Personalized Treatment Approaches 

Uncovering Breast Cancer: The Power of Early Stage Ultrasound 

Rehabilitation of Hand Dexterity Following Hematologic Treatment-Associated Deconditioning 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA.

2.

Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.

3.

Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap

4.

Novel topical fluorescent imaging technique rapidly and safely detects basal cell carcinoma

5.

Potential new therapy for childhood brain cancer could heal treatment-resistant tumors

1.

What is Hemorrhagic Cystitis and How to Manage its Symptoms

2.

How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education?

3.

Blood Donation Sustainability Through Behavioral Science

4.

Emerging Therapies and Technologies Reshaping Oncology: Innovations and Impact in 2025

5.

Essential Developments in Oncology for Healthcare Excellence

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

2.

Navigating the Complexities of Ph Negative ALL - Part XVI

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

5.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot